GlassScriptPhysician profile
Deirdre Cristea
NPI 1073354932
$3,255.44
in general payments reported to CMS, 2019-2025
41 companies · $2,746 in 2025
The $2,746 reported for 2025 was more than what 96% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $509 · 2025: $2,746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,156 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,156.44 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $289.72 | 2024-2025 | Jakafi, Monjuvi, Niktimvo |
| Merck Sharp & Dohme LLC | $272.20 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $257.69 | 2024-2025 | Enhertu, Imfinzi, Calquence |
| Daiichi Sankyo INC. | $199.88 | 2024-2025 | Enhertu |
| Celgene Corporation | $189.09 | 2025 | Reblozyl, Opdualag |
| Pfizer INC. | $185.85 | 2025 | |
| Novartis Pharmaceuticals Corporation | $166.18 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $140.16 | 2025 | Ninlaro |
| Glaxosmithkline, LLC. | $104.07 | 2025 | Ojjaara, Blenrep |
| Adc Therapeutics America, INC. | $94.28 | 2024-2025 | |
| Geron Corporation | $91.81 | 2025 | Rytelo |
| Sumitomo Pharma America, INC. | $91.57 | 2024-2025 | Orgovyx |
| Legend Biotech USA INC. | $91.28 | 2025 | Carvykti |
| E.R. Squibb & Sons, L.L.C. | $84.65 | 2025 | Opdivo |
| Alexion Pharmaceuticals, INC. | $80.49 | 2024-2025 | Ultomiris |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deirdre Cristea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.